Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
R&D Inquiry Quote
Contact Us Telecon Calls

Apta-Index™: VEGF-stimulated HUVECs (ID# 231)

Back to Search Results

VEGF-stimulated HUVECs (ID# 231)

VEGF-stimulated HUVECs
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
Peptide VEGF-stimulated human umbilical vein endothelial cells (HUVECs) Tissue N/A nM (reported value) In vivo mice. N/A If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding. See also PVV peptide , which also results in tumor growth suppression.
See also DRW peptide , which contains the same WRP epitope resulting in suppression of tumor growth.
15 2017.31 g/mole

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Asai et al. "Suppression of tumor growth by novel peptides homing to tumor-derived new blood vessels." FEBS Letters, 510(2002): 206-210.

Have your aptamer oligo synthesized by one of our AFFILIATES

Community Feedback

Aptagen, LLC | 250 North Main Street | Jacobus, PA 17407

Forget Antibodies. Use Aptamers!™ Forget Antibodies. Use Aptamers!™
Contact Us Telecon Calls